Actively Recruiting
ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment
Led by University of Salamanca · Updated on 2026-02-27
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are: * What changes in voice and breathing are observed in adults with dysarthria after ABI? * Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype? Participants will: * Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds. * Perform breathing tests using a spirometer to assess lung function. * Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity. About 97 to 101 participants will take part. The results will help speech therapists better detect, evaluate, and treat dysarthria in adults after brain injury.
CONDITIONS
Official Title
ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older at the time of enrollment
- Diagnosed with acquired brain injury (stroke, traumatic brain injury, or brain tumor)
- Ability to provide written informed consent or through a legally authorized representative
- Preserved cognitive function with Mini-Mental State Examination (MMSE) score of 24 or higher
You will not qualify if you...
- History of chronic respiratory diseases such as COPD or asthma
- History of hearing impairments affecting speech evaluation
- Additional neurological or neurodegenerative disorders besides acquired brain injury
- History of voice disorders or dysphonia before acquired brain injury
- Persistent pharyngeal symptoms like mucus, secretions, or foreign body sensation interfering with speech assessment
- Inability to comply with assessment protocol or complete required sessions
- Presence of aphasia preventing participation in speech tasks such as reading, repetition, or spontaneous speech production
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Salamanca
Salamanca, Salamanca, Spain, 34007
Actively Recruiting
Research Team
A
AHMED ARGOUBI, Speech Language Pathologist
CONTACT
A
Ana-María Martín-Nogueras, Investigator/ Profesor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here